Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
37 hedge funds and large institutions have $19.4M invested in Orgenesis Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 4 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 6
5% less funds holding
Funds holding: 39 → 37 (-2)
12% less capital invested
Capital invested by funds: $22.2M → $19.4M (-$2.76M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$376K |
| 2 |
Renaissance Technologies
New York
|
+$204K |
| 3 |
JP Morgan Chase
New York
|
+$182K |
| 4 |
State Street
Boston,
Massachusetts
|
+$172K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$68.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.75M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$187K |
| 3 |
VF
Virtu Financial
New York
|
-$61K |
| 4 |
GHA
GW Henssler & Associates
Kennesaw,
Georgia
|
-$55K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$39.6K |
ORGS Hedge Fund Activity: Q4 2020 in Review
37 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q4 2020, worth a combined $19.4M — down 12% from $22.2M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ORGS and 2 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 21 added.
The largest buyer was BlackRock, adding an estimated $376K. The largest seller was Sphera Funds Management, cutting an estimated $1.75M.
- 37 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q4 2020, down from 39 in Q3 2020.
- Funds reported $19.4M of Orgenesis Inc. Common Stock stock for Q4 2020, down 12% quarter-over-quarter.
- 2 funds opened new Orgenesis Inc. Common Stock positions in Q4 2020 and 4 closed out, a net change of -2 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q4 2020 was BlackRock, an estimated $376K added.
- The largest Orgenesis Inc. Common Stock seller in Q4 2020 was Sphera Funds Management, an estimated $1.75M sold.
Based on aggregated 13F filings for Q4 2020.